Get the Stockscreener App
98.96
0.54%
-0.54
After Hours:
98.99
0.03
+0.03%
Illumina Inc stock is traded at $98.96, with a volume of 1.32M.
It is down -0.54% in the last 24 hours and down -3.69% over the past month.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
See More
Previous Close:
$99.50
Open:
$100.41
24h Volume:
1.32M
Relative Volume:
0.77
Market Cap:
$15.21B
Revenue:
$4.28B
Net Income/Loss:
$1.26B
P/E Ratio:
12.53
EPS:
7.9
Net Cash Flow:
$943.00M
1W Performance:
+8.75%
1M Performance:
-3.69%
6M Performance:
+37.44%
1Y Performance:
-31.85%
1-Day Range:
$98.50
$102.31
1-Week Range:
$90.10
$102.31
52-Week Range:
$68.70
$156.66
Illumina Inc Stock (ILMN) Company Profile
Name
Illumina Inc
Sector
Industry
Phone
(858) 202-4500
Address
5200 ILLUMINA WAY, SAN DIEGO, CA
Compare ILMN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ILMN
Illumina Inc
|
98.96 | 15.29B | 4.28B | 1.26B | 943.00M | 7.90 |
|
TMO
Thermo Fisher Scientific Inc
|
557.99 | 205.36B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
220.77 | 149.22B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
637.13 | 51.48B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
145.68 | 40.54B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
218.67 | 36.05B | 15.70B | 1.24B | 2.01B | 6.9036 |
Illumina Inc Stock (ILMN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-12-25 | Downgrade | Daiwa Securities | Outperform → Neutral |
| Jul-11-25 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| Mar-04-25 | Reiterated | Citigroup | Neutral |
| Feb-28-25 | Downgrade | HSBC Securities | Buy → Hold |
| Feb-10-25 | Downgrade | Barclays | Equal Weight → Underweight |
| Feb-07-25 | Downgrade | TD Cowen | Buy → Hold |
| Dec-11-24 | Downgrade | Citigroup | Buy → Neutral |
| Nov-12-24 | Resumed | Morgan Stanley | Equal-Weight |
| Oct-17-24 | Upgrade | HSBC Securities | Hold → Buy |
| Aug-28-24 | Upgrade | Argus | Hold → Buy |
| Aug-16-24 | Upgrade | Daiwa Securities | Neutral → Buy |
| Aug-14-24 | Upgrade | Barclays | Underweight → Equal Weight |
| Aug-14-24 | Upgrade | TD Cowen | Hold → Buy |
| Jul-10-24 | Upgrade | Citigroup | Neutral → Buy |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Jan-16-24 | Downgrade | HSBC Securities | Buy → Hold |
| Jan-04-24 | Downgrade | TD Cowen | Outperform → Market Perform |
| Dec-18-23 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Dec-15-23 | Upgrade | Bernstein | Underperform → Mkt Perform |
| Dec-14-23 | Initiated | Guggenheim | Buy |
| Dec-14-23 | Initiated | Stephens | Overweight |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Dec-12-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Dec-11-23 | Upgrade | Citigroup | Sell → Neutral |
| Nov-10-23 | Downgrade | Canaccord Genuity | Buy → Hold |
| Sep-28-23 | Initiated | Bernstein | Underperform |
| Jul-05-23 | Resumed | JP Morgan | Neutral |
| Jan-25-23 | Downgrade | Argus | Buy → Hold |
| Jan-05-23 | Initiated | Scotiabank | Sector Perform |
| Dec-12-22 | Downgrade | Citigroup | Neutral → Sell |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Oct-04-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Sep-28-22 | Upgrade | Evercore ISI | In-line → Outperform |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| Jul-13-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Jan-18-22 | Upgrade | Stifel | Hold → Buy |
| Jan-11-22 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-07-22 | Upgrade | BofA Securities | Underperform → Neutral |
| Jan-06-22 | Resumed | Morgan Stanley | Equal-Weight |
| Jan-06-22 | Resumed | Piper Sandler | Overweight |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-19-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Jun-01-21 | Upgrade | Evercore ISI | Underperform → In-line |
| Mar-31-21 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Mar-31-21 | Upgrade | Canaccord Genuity | Hold → Buy |
| Mar-03-21 | Initiated | Barclays | Underweight |
| Dec-22-20 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-17-20 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-13-20 | Downgrade | Guggenheim | Buy → Neutral |
| Sep-30-20 | Initiated | Atlantic Equities | Overweight |
| Sep-29-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Sep-22-20 | Downgrade | Stifel | Buy → Hold |
| Sep-22-20 | Downgrade | UBS | Buy → Neutral |
| Sep-21-20 | Upgrade | Guggenheim | Neutral → Buy |
| Sep-21-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-09-20 | Initiated | Morgan Stanley | Equal-Weight |
| Aug-07-20 | Downgrade | Evercore ISI | In-line → Underperform |
| Aug-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-07-20 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-24-20 | Downgrade | Citigroup | Buy → Neutral |
| Apr-21-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-08-20 | Initiated | Wells Fargo | Underweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Jan-02-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-15-19 | Initiated | Stifel | Buy |
| Oct-25-19 | Initiated | Guggenheim | Buy |
View All
Illumina Inc Stock (ILMN) Latest News
10x sues rival Illumina over gene-sequencing patents - Reuters
Candlestick signals on Illumina Inc. stock todayJuly 2025 Weekly Recap & Community Consensus Stock Picks - newser.com
10x Genomics (TXG) Takes Legal Action Against Illumina Over Pate - GuruFocus
Illumina: Innovation Outweighs Short-Term RisksBuy Ahead Of Q3 Earnings (NASDAQ:ILMN) - Seeking Alpha
Illumina faces patent lawsuits from 10x Genomics (ILMN:NASDAQ) - Seeking Alpha
Illumina Hit with 10X Genomics Patent Suits Over Sequencing Tech - Bloomberg Law News
Can Illumina Inc. (ILU) stock surprise with quarterly resultsMarket Growth Report & Technical Analysis for Trade Confirmation - newser.com
Go big and go ome - Illumina
Illumina Inc. Stock Rallies 4.2%, Outperforms Peers - 富途牛牛
JPMorgan, Alibaba, Columbia Banking System And A Health Care Stock On CNBC's 'Final Trades' - Benzinga
Technical analysis overview for Illumina Inc. stockTrade Volume Report & Weekly Stock Breakout Alerts - newser.com
Illumina Inc (ILU.HA) stock price, news, quote and history - Yahoo
Will Illumina Inc. (ILU) stock deliver stable dividendsWeekly Risk Report & Community Consensus Trade Signals - newser.com
Is Illumina Inc. stock safe for conservative investors2025 Price Momentum & Scalable Portfolio Growth Methods - newser.com
Will Illumina Inc. stock remain a Wall Street favorite2025 Market Sentiment & Fast Moving Trade Plans - newser.com
Why Illumina Inc. (ILU) stock benefits from AI revolutionWeekly Investment Report & Verified Stock Trade Ideas - newser.com
Should I buy Illumina Inc. (ILU) stock before earnings seasonWeekly Trend Summary & Community Supported Trade Ideas - newser.com
Is Illumina Inc. (ILU) stock a buy on weaknessJuly 2025 Fed Impact & Technical Buy Zone Confirmations - newser.com
Published on: 2025-10-20 23:40:58 - nchmf.gov.vn
Real time pattern detection on Illumina Inc. stockJuly 2025 WrapUp & Daily Volume Surge Trade Alerts - newser.com
Backtesting results for Illumina Inc. trading strategiesGDP Growth & AI Forecast Swing Trade Picks - newser.com
Illumina, Inc. (ILMN) Stock Analysis: Navigating Market Volatility with a 16.83% Upside Potential - DirectorsTalk Interviews
Sentiment analysis tools applied to Illumina Inc.July 2025 Market Mood & Safe Swing Trade Setups - newser.com
Will Illumina Inc. (ILU) stock gain from green policiesOil Prices & Accurate Technical Buy Alerts - newser.com
Diwali marks Illumina’s exciting year ahead - Illumina
CapEx per share of Illumina, Inc. – VIE:ILMN - TradingView
What drives Illumina Inc ILU stock priceLong-Term Growth Stocks & Outstanding Capital Tips - earlytimes.in
Long term hold vs stop loss in Illumina Inc.Bear Alert & AI Powered Buy/Sell Recommendations - newser.com
Illumina, Inc.Common Stock (NQ: ILMN - FinancialContent
Why Illumina Inc. stock is in analyst buy zoneJuly 2025 Macro Moves & Free Community Consensus Stock Picks - nchmf.gov.vn
Illumina, Inc. (ILMN) stock forecast and price target - Yahoo
Is Illumina Inc. (ILU) stock positioned for secular growthJuly 2025 Review & Real-Time Stock Movement Alerts - nchmf.gov.vn
Can Illumina Inc. stock resist sector downturnsMarket Sentiment Report & Real-Time Volume Spike Alerts - nchmf.gov.vn
Will Illumina Inc. stock continue dividend increasesTreasury Yields & Technical Pattern Recognition Alerts - nchmf.gov.vn
Why Illumina Inc. stock could see breakout soonStock Surge & Stepwise Entry/Exit Trade Alerts - nchmf.gov.vn
Aug Gainers: Will Illumina Inc. stock continue dividend increases2025 Short Interest & Accurate Buy Signal Alerts - nchmf.gov.vn
What technical charts say about Illumina Inc. stockJuly 2025 Trade Ideas & Long-Term Investment Growth Plans - nchmf.gov.vn
Is Illumina, Inc. (NASDAQ:ILMN) Potentially Undervalued? - 富途牛牛
Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot - PR Newswire
Illumina Inc Stock (ILMN) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.03%
1.76%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):